The outcome of patients with high ‐risk MDS achieving stable disease after treatment with 5‐Azacytidine. A retrospective analysis of the Hellenic (Greek) MDS Study Group

Hematological Oncology,Volume 0, Issue ja, -Not available-.

Source: Hematological Oncology - August 21, 2018 Category: Hematology Authors: Sotirios G.Papageorgiou , Christos K.Kontos , IoannisKotsianidis , DiamantinaVasilatou , ArgyrisSymeonidis , AthanasiosGalanopoulos , AnthiBouchla , EleftheriaHatzimichael , PanagiotisRepousis , PanagiotisZikos , Nora ‐AthinaViniou , Source Type: research